Schizophrenia is an often devastating neuropsychiatric illness whose etiology remains unknown despite considerable study. Genetic factors have been strongly and consistently implicated in its etiology via the quasi- experimental tools of family, adoption, and twin studies. Historically, the molecular genetics of schizophrenia has been controversial due to a disturbing pattern of highly publicized single studies followed by multiple non-replications. Developments in the scientific literature over the past two years very strongly suggest a fundamental shift in the field. By our count, there are 12 genes for which there is compelling evidence from multiple different samples/types of evidence for involvement in the etiology of schizophrenia. Therefore, it seems evident that research into the molecular genetics of schizophrenia has """"""""turned the corner"""""""". However, the field is at a critical juncture. To avoid uncertainty, confusion, and disillusionment, there is an urgent need for additional study of these genes in large and well-characterized samples. To achieve this end, we propose here an efficient, brief, inexpensive, but highly rigorous exploration of these 12 candidate genes for schizophrenia. Our overarching goals are essentially twofold, to add to the body of data on these genes in one of the largest case-control studies yet conducted for schizophrenia and to extend this work using additional phenotypes in a well-characterized sample. We propose a genetic case-control association study of 800 genetic markers in 12 candidate genes for schizophrenia. All of these genes are expressed in brain regions relevant to schizophrenia and have substantial evidence via prior linkage and association studies. Our marker coverage is more systematic and complete than in any prior study. Cases are ~1,000 individuals with schizophrenia who participated in CATIE (a large, NIMH-funded trial of multiple antipsychotic medications). Controls are from a US national sample and will be matched by age band, gender, and ancestry. Ascertainment, phenotyping, blood sampling, and cell line creation were all funded via other NIMH grants and all samples will be available at the start of this project. The analytic methods are advanced and take into account the known weaknesses of this study design. Therefore, we request support for only genotyping and data analysis. We believe that the results of our study will be highly informative and are essential to the field at this critical juncture in the hunt for genes mediating liability to schizophrenia. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
1R01MH074027-01A1
Application #
7030409
Study Section
Behavioral Genetics and Epidemiology Study Section (BGES)
Program Officer
Lehner, Thomas
Project Start
2006-03-15
Project End
2008-02-28
Budget Start
2006-03-15
Budget End
2007-02-28
Support Year
1
Fiscal Year
2006
Total Cost
$453,023
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Genetics
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Xavier, Rose Mary; Dungan, Jennifer R; Keefe, Richard S E et al. (2018) Polygenic signal for symptom dimensions and cognitive performance in patients with chronic schizophrenia. Schizophr Res Cogn 12:11-19
Brandl, E J; Tiwari, A K; Zai, C C et al. (2016) Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample. Pharmacogenomics J 16:352-6
Wang, Xin; Epstein, Michael P; Tzeng, Jung-Ying (2014) Analysis of gene-gene interactions using gene-trait similarity regression. Hum Hered 78:17-26
Steinberg, S; de Jong, S; Mattheisen, M et al. (2014) Common variant at 16p11.2 conferring risk of psychosis. Mol Psychiatry 19:108-14
Ramsey, Timothy L; Brennan, Mark D (2014) Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial. Schizophr Res 160:73-9
Ramsey, Timothy L; Liu, Qian; Massey, Bill W et al. (2013) Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE study. Schizophr Res 149:21-5
de Candia, Teresa R; Lee, S Hong; Yang, Jian et al. (2013) Additive genetic variation in schizophrenia risk is shared by populations of African and European descent. Am J Hum Genet 93:463-70
Zhao, Zhongming; Webb, Bradley T; Jia, Peilin et al. (2013) Association study of 167 candidate genes for schizophrenia selected by a multi-domain evidence-based prioritization algorithm and neurodevelopmental hypothesis. PLoS One 8:e67776
Agim, Zeynep Sena; Esendal, Melda; Briollais, Laurent et al. (2013) Discovery, validation and characterization of Erbb4 and Nrg1 haplotypes using data from three genome-wide association studies of schizophrenia. PLoS One 8:e53042
Jackson, Kia J; Fanous, Ayman H; Chen, Jingchun et al. (2013) Variants in the 15q25 gene cluster are associated with risk for schizophrenia and bipolar disorder. Psychiatr Genet 23:20-8

Showing the most recent 10 out of 61 publications